Literature DB >> 14581352

Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.

Kristin K Zorn1, Amir A Jazaeri, Christopher S Awtrey, Ginger J Gardner, Samuel C Mok, Jeff Boyd, Michael J Birrer.   

Abstract

PURPOSE: As with many cancers thought to be of epithelial origin, expression profiling studies of ovarian cancer have relied on a variety of sources of normal cells for comparison with tumors, including whole ovary samples (WO), ovarian surface epithelium (OSE) exposed to short-term culture, and immortalized OSE cell lines (IOSE). Our purpose was to assess the impact of the use of different types of normal controls on the determination of gene expression alterations in ovarian cancer studies. EXPERIMENTAL
DESIGN: We compared the gene expression profiles generated on an 11,000-element cDNA microarray of OSE brushings, whole ovary samples, short-term cultures of normal OSE, SV40 large T antigen-immortalized OSE cell lines, and telomerase-immortalized OSE cell lines. The function of the groups as normal controls was then assessed by separate comparisons of each group to a set of 24 serous ovarian carcinoma samples.
RESULTS: The normal groups formed robust, distinct clusters in hierarchical clustering and multidimensional scaling. The Pearson correlation coefficient for all combinations of any two of the groups ranged from 0.04 to 0.54, emphasizing the disparity of the groups. In the gene lists produced by comparing each normal group with the ovarian cancer samples, the majority of genes were unique to that normal-cancer comparison, with no gene appearing on all five lists.
CONCLUSIONS: These results suggest that the selection of a normal control to compare with epithelial ovarian cancer samples in microarray studies strongly influences the genes that are identified as differentially expressed and complicates comparison with studies using a different normal control.

Entities:  

Mesh:

Year:  2003        PMID: 14581352

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  37 in total

1.  miRNAs in human cancer.

Authors:  Xiaomin Zhong; George Coukos; Lin Zhang
Journal:  Methods Mol Biol       Date:  2012

2.  Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteome.

Authors:  Bunja Rungruang; Brian L Hood; Mai Sun; Ebony Hoskins; Thomas P Conrads; Kristin K Zorn
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

3.  Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors.

Authors:  Hirdesh Kumar; Anup Shah; M Elizabeth Sobhia
Journal:  J Mol Model       Date:  2011-08-12       Impact factor: 1.810

4.  p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.

Authors:  Tulsiram Prathapam; Alexey Aleshin; Yinghui Guan; Joe W Gray; G Steven Martin
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 5.  Classification of ovarian cancer: a genomic analysis.

Authors:  Michael P Stany; Tomas Bonome; Fred Wamunyokoli; Kristen Zorn; Laurent Ozbun; Dong-Choon Park; Ke Hao; Jeff Boyd; Anil K Sood; David M Gershenson; Ross S Berkowitz; Samuel C Mok; Michael J Birrer
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 6.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

7.  Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates.

Authors:  Adeeti V Ullal; Vanessa Peterson; Sarit S Agasti; Suan Tuang; Dejan Juric; Cesar M Castro; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

8.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.

Authors:  Lin Zhang; Stefano Volinia; Tomas Bonome; George Adrian Calin; Joel Greshock; Nuo Yang; Chang-Gong Liu; Antonis Giannakakis; Pangiotis Alexiou; Kosei Hasegawa; Cameron N Johnstone; Molly S Megraw; Sarah Adams; Heini Lassus; Jia Huang; Sippy Kaur; Shun Liang; Praveen Sethupathy; Arto Leminen; Victor A Simossis; Raphael Sandaltzopoulos; Yoshio Naomoto; Dionyssios Katsaros; Phyllis A Gimotty; Angela DeMichele; Qihong Huang; Ralf Bützow; Anil K Rustgi; Barbara L Weber; Michael J Birrer; Artemis G Hatzigeorgiou; Carlo M Croce; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

9.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

10.  Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Authors:  Nicola Potter; Aikaterini Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic N P Thompson; Thomas S Jacques; Brian Harding; David G T Thomas; Rodger W Palmer; Jeremy Rees; John Darling; Tracy J Warr
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.